These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 5062560)
1. Chlorpromazine and the eye of the dog. IV. Reversibility of ocular lesions. Barron CN; Rubin LF; Steelman RL Exp Mol Pathol; 1972 Apr; 16(2):163-8. PubMed ID: 5062560 [No Abstract] [Full Text] [Related]
2. Chlorpromazine and the eye of the dog. V. Attempt to produce lenticular lesions. Barron CN; Rubin LF; Steelman RL Exp Mol Pathol; 1972 Apr; 16(2):169-71. PubMed ID: 5062561 [No Abstract] [Full Text] [Related]
3. Chlorpromazine and the eye of the dog. VI. A comparison of phenothiazine tranquilizers. Barron CN; Murchison TE; Rubin LF; Rubin ML; Herron W; Muscarella M; Birkhead H Exp Mol Pathol; 1972 Apr; 16(2):172-9. PubMed ID: 5062562 [No Abstract] [Full Text] [Related]
4. Ocular effects of phenothiazine derivatives and reversibility. Mathalone MB Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561 [No Abstract] [Full Text] [Related]
5. Chlorpromazine and the eye of the dog. 3. Natural daylight versus artificial light. Barron CN; Rubin LF; Steelman RL Exp Mol Pathol; 1972 Apr; 16(2):158-62. PubMed ID: 5014079 [No Abstract] [Full Text] [Related]
6. Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study. Prien RF; DeLong SL; Cole JO; Levine J Arch Gen Psychiatry; 1970 Nov; 23(5):464-8. PubMed ID: 5478574 [No Abstract] [Full Text] [Related]
7. Incidence of late "melanosis" side effects in chronic mental patients after long term phenothiazine therapy. Forrest FM; Snow HL; Erickson G; Geiter CW; Laxson GO Proc West Pharmacol Soc; 1966; 9():18-20. PubMed ID: 5958492 [No Abstract] [Full Text] [Related]
8. Ocular melanosis with special reference to chlorpromazine. Cameron ME Br J Ophthalmol; 1967 May; 51(5):295-305. PubMed ID: 6022771 [No Abstract] [Full Text] [Related]
9. Chlorpromazine and the eye of the dog. A chronic study. Rubin LF; Murchison TE; Barron CN Exp Mol Pathol; 1970 Aug; 13(1):111-7. PubMed ID: 4918198 [No Abstract] [Full Text] [Related]
11. [Study of the aqueous humor after prolonged treatment with neuroleptics]. Verrey F; Cuendet JF; Nouri A Ophthalmologica; 1972; 165(3-4):200-2. PubMed ID: 4680181 [No Abstract] [Full Text] [Related]
12. Incidence and significance of chlorpromazine-induced eye changes. De Long SL Dis Nerv Syst; 1968 Mar; 29(3):Suppl:19-22. PubMed ID: 4876741 [No Abstract] [Full Text] [Related]
13. Chlorpromazine and the eye of the dog. An electron microscopic study. Tousimis AJ; Barron CN Exp Mol Pathol; 1970 Aug; 13(1):89-110. PubMed ID: 5459857 [No Abstract] [Full Text] [Related]
14. Some iatrogenic ocular diseases from systemically administered drugs. Bernstein HN Int Ophthalmol Clin; 1970; 10(3):553-619. PubMed ID: 4933547 [No Abstract] [Full Text] [Related]
15. Asymmetric anterior segment changes induced by chlorpromazine. Deluise VP; Flynn JT Ann Ophthalmol; 1981 Aug; 13(8):953-5. PubMed ID: 7294636 [TBL] [Abstract][Full Text] [Related]
16. [Ocular complications in long-term chlorpromazine treatment]. Klíma M; Klímová A Cesk Oftalmol; 1977 Sep; 33(5):349-52. PubMed ID: 922908 [No Abstract] [Full Text] [Related]
17. Ocular complications of phenothiazines. Mathalone MB Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613 [No Abstract] [Full Text] [Related]
18. [Ultrastructural study of corneal thickening in the course of chlorpromazine treatment]. Pouliquen Y; Graf B; Bisson J; Feuvrier YM; Delattre A Arch Ophtalmol Rev Gen Ophtalmol; 1970 Nov; 30(11):769-82. PubMed ID: 4250388 [No Abstract] [Full Text] [Related]